19 Apr 2026
Quinazoline-sulfonamide hybrids as multitarget anticancer agents: inhibition of carbonic anhydrase IX/XII isoforms and VEGFR-2 with in vitro and in silico validationPublisher siteMolecular Diversity, Enzyme function and inhibition
UniversitiesSamar S. Tawfik
Active, last published 2026
Samar S.
Tawfik
Scholar“Research profile drawn from open scholarly records.”
Mansoura University
Claim Your Profile6
H-index
174
Citations
Samar has not officially claimed their profile. If you are Samar, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Samar S. Tawfik will appear here once their profile is updated.
02 · Reach
Publication output and reach
Samar's work has been cited 174 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchMansoura UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works1 Feb 2026
New Benzimidazole Scaffolds Tagged With Isatin/Thiourea Motifs as Anti-Cancer Agents: Promising Approach for VEGFR-2 Inhibition.Publisher sitePubMed, Angiogenesis and VEGF in Cancer
18 Feb 20252cites
New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insightsPublisher siteBioorganic & Medicinal Chemistry, Synthesis and biological activity
1 Nov 2024Open access11cites
Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 InhibitorsPublisher siteDrug Design Development and Therapy, Quinazolinone synthesis and applications
4 Jul 2024Open access21cites
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico StudyPublisher siteMolecules, Synthesis and biological activity
1 Jan 2024Open access21cites
<i>S</i>-Alkylated quinazolin-4(3<i>H</i>)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking studyPublisher siteRSC Advances, Quinazolinone synthesis and applications
1 Jan 2024Open access6cites
Design, synthesis, and <i>in vitro</i> and <i>in vivo</i> biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agentsPublisher siteRSC Advances, Click Chemistry and Applications
24 Jan 2023Open access44cites
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and <i>in silico</i> studyPublisher siteJournal of Enzyme Inhibition and Medicinal Chemistry, Synthesis and biological activity
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Samar?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you